Business Standard

Medico Remedies Share Price

Know More
NSEBSE

48.401.45 (3.09%)

03:53 PM,16th Apr 2024

47.570.57 (1.21%)

04:01 PM,16th Apr 2024

BSE : 540937

NSE : MEDICO

Sector : Health care

ISIN Code : INE630Y01024

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Apr 16 2024 | 04:01 PM IST

Market Cap (₹ Cr)

401

Turnover (₹ Cr)

0.23

Volume (Shares)

466933

Face Value

2

52-WK High

100.70

52-WK High Date

31 May 2023

52-WK Low

44.50

52-WK Low Date

15 Apr 2024

All Time High

100.70

All Time High Date

31 May 2023

All Time Low

16.52

All Time Low Date

10 Aug 2022

Medico Remedies Ltd

Medico Remedies Limited was incorporated as a private limited company with the name Medico Remedies Private Limited on March 18 1994. The status of the Company was changed to a public limited company and the name of the Company was changed to Medico Remedies Limited on March 6 2017. Medico Remedies is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective Beta-Lactums cephalosporins antimalarial antiretroviral anti-ulcer drugs and antacids vitamins haematinics and other supplements. Further in addition to the above the Company also has manufacturing and marketing capabilities in other drugs such as NSAIDS antihistaminic antidiabetics cardio vascular drugs diuretics anti-epileptics combination drug kits syrups and cream & gel for various therapeutic segments.The Company began its operations in the year 1994 with manufacturing and servicing of diuretics anti-malarials NSAIDS tablets anti-reterovirals anti-ulcer drugs and anti-acids tablets. Over the years the company has expanded its scale and scope of operations and currently the Company is engaged in manufacture of formulations for various medicines. As part of this expansion in the year 1999 & 2002 the company has acquired two adjacent plots of 1023.50 sq. metres each respectively for setting up the plant at Palghar Maharashtra. The plant is divided into two units i.e. general formulations unit and betalactam unit; the beta lactam unit is further divided into two segments -penicillin and cephalosporins.The Company has built a strong relationship with its customers for drug formulations. The clients include Indian as well as foreign pharmaceutical companies like Anphar Limited Saad Medical Manfes Pharmaceuticals & Chemical Industries Award Global Company Limited Directorate of Health Services (DHS Maharashtra) to name a few. The Company also earns revenue from the sale of licenses such as FMS license FPS license and MESI license.

Medico Remedies Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

401

EPS - TTM (₹) [S]

0.84

P/E Ratio (X) [S]

8.43

Face Value (₹) 2
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]5.74
P/B Ratio (₹) [S]8.43
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

45.30

49.00

Week Low/High

44.50

49.00

Month Low/High

44.50

80.00

Year Low/High

44.50

101.00

All time Low/High

3.35

101.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week0.27%0.94%-2.33-2.19%
1 Month-38.90%-39.23%0.410.57%
3 Month-44.67%-44.81%-0.250.52%
6 Month-32.07%-31.73%10.2412.24%
1 Year-44.95%-44.94%20.7124.23%
3 Year%%49.3851.51%

Company Info

Company Information

Independent Director : Deepak Vekaria

Registered Office: 1105/1106 11-Flr Hubtown Solar, N S Phadke Marg Andheri East,Mumbai,Maharashtra-400069 Ph: 91-22-2670 1055/66

Email:info@medicoremedies.com

URL:http://www.medicoremedies.com